Xycrobe Therapeutics is developing technology that uses microbes (found in the microbiome) as delivery vehicles for biotherapeutics that is headquartered in San Diego, California and was founded in 2014 by Thomas Hitchcock. The company aims develop solutions for several clinical indications, with an initial focus on inflammatory skin diseases. Xycrobe Therapeutics research aims to build off the findings of the Human Microbiome Project.
Founding of Xycrobe Therapeutics
Xycrobe Therapeutics was founded in 2014 by Thomas Hitchcock.
Jeong Ho Kim
Mun Su Rhee
Documentaries, videos and podcasts
Spotlight on JLabs: Xycrobe Therapeutics
December 4, 2015
Xycrobe promo 2017
March 27, 2017